Valuation: Abbott Laboratories

Market Cap 170B 258,365B 152B 142B 129B 243B 16,494B 244B 1,704B 668B 8,409B 640B 626B 26,985B P/E 2026 *
28.8x
P/E 2027 * 22.4x
Enterprise Value 194B 294,656B 174B 161B 147B 277B 18,811B 279B 1,943B 762B 9,590B 730B 714B 30,776B EV / Sales 2026 *
3.87x
EV / Sales 2027 * 3.51x
Free-Float
86.16%
Yield 2026 *
2.61%
Yield 2027 * 2.78%
1 day-0.25%
1 week+0.97%
Current month-0.50%
1 month-5.52%
3 months+6.60%
6 months+3.81%
Current year-16.83%
1 week 39,160
Extreme 39160
40,540
1 month 38,660
Extreme 38660
42,300
Current year 30,380
Extreme 30380
49,620
1 year 30,380
Extreme 30380
52,150
3 years 19,182.5
Extreme 19182.5
53,525
5 years 5,360.5
Extreme 5360.5
53,525
10 years 145
Extreme 145
53,525
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.25%+0.97% - - 170B
+1.08%+2.19%-25.26%+2.98% 170B
+0.41%+2.48%-8.26%+17.83% 112B
+0.10%+0.72%-25.06%+3.98% 106B
+2.34%+1.21%-47.49%-10.79% 73.6B
+0.94%+5.10%+3.40%+74.45% 61.32B
+0.12%+2.73%+13.09%+67.70% 52.89B
+0.27%+3.81%-2.93%-30.95% 49.78B
+0.65%-0.42%-17.90%+16.73% 40.43B
-0.37%-1.47%+23.54%+1.22% 31.85B
Average +0.53%+1.29%-9.65%+15.90% 77.64B
Weighted average by Cap. +0.54%+1.54%-15.18%+13.53%

Financials

2026 *2027 *
Net sales 50.2B 76,108B 44.84B 41.71B 37.94B 71.63B 4,859B 71.94B 502B 197B 2,477B 189B 184B 7,949B 54.53B 82,671B 48.7B 45.31B 41.21B 77.81B 5,278B 78.14B 545B 214B 2,691B 205B 200B 8,635B
Net income 6.21B 9,418B 5.55B 5.16B 4.69B 8.86B 601B 8.9B 62.12B 24.34B 307B 23.33B 22.82B 984B 7.89B 11,967B 7.05B 6.56B 5.97B 11.26B 764B 11.31B 78.93B 30.93B 389B 29.64B 28.99B 1,250B
Net Debt 23.94B 36,292B 21.38B 19.89B 18.09B 34.16B 2,317B 34.3B 239B 93.79B 1,181B 89.9B 87.93B 3,791B 20.96B 31,771B 18.72B 17.41B 15.84B 29.9B 2,028B 30.03B 210B 82.11B 1,034B 78.7B 76.98B 3,318B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
08/10/26 ARS 39,740.00 -0.25% 613
07/10/26 ARS 39,840.00 +0.86% 1,080
06/10/26 ARS 39,500.00 -1.89% 1,312
05/10/26 ARS 40,260.00 +1.67% 3,091
02/10/26 ARS 39,600.00 +0.61% 1,969
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
98.49USD
Average target price
120.72USD
Spread / Average Target
+22.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories